Home
Browse
Search
Statistics
About
Usage
PMID: 26136557
Woodward OM
ABCG2: the molecular mechanisms of urate secretion and gout.
Am J Physiol Renal Physiol. 2015 Sep 15;309(6):F485-8. doi: 10.1152/ajprenal.00242.2015. Epub 2015 Jul 1.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
12
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:12:178
status:
NEW
view ABCG2 p.Gln141Lys details
This review will highlight the recent work to identify the first important human uric acid secretory transporter, ABCG2, and the identification of a common causal ABCG2 variant,
Q141K
, for hyperuricemia and gout.
Login to comment
13
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:13:26
status:
NEW
view ABCG2 p.Gln141Lys details
uric acid; kidney; ABCG2;
Q141K
; gout; hyperuricemia URIC ACID IS A TERMINAL METABOLITE of the purine metabolic pathway in humans and is only weakly soluble in water or blood.
Login to comment
35
ABCG2 p.Ser187Ala
X
ABCG2 p.Ser187Ala 26136557:35:298
status:
NEW
view ABCG2 p.Ser187Ala details
Using a Xenopus oocyte expression system, we demonstrated ABCG2 to be a high-capacity urate transporter with ABCG2-mediated c-14 uric acid efflux highly dependent on the intracellular concentration, and could be blocked by a specific ABCG2 inhibitor, FTC, or with a single amino acid substitution,
S187A
.
Login to comment
38
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:38:13
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:38:153
status:
NEW
view ABCG2 p.Gln141Lys details
We found the
Q141K
variant had similar total and surface expression levels in the Xenopus oocytes but showed a 54% reduction in urate transport, marking
Q141K
as a loss-of-function mutation (17, 18, 30).
Login to comment
39
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:39:68
status:
NEW
view ABCG2 p.Gln141Lys details
A population-based study of 14,783 individuals supported rs2231142 (
Q141K
) as a causal variant for gout and increased SUA levels, marking the rs2231142 as a rare example in support of the common disease-common variant hypothesis (30).
Login to comment
42
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:42:97
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln126*
X
ABCG2 p.Gln126* 26136557:42:122
status:
NEW
view ABCG2 p.Gln126* details
Matsuo et al. compared gouty and normal cohorts of Japanese males and found two ABCG2 mutations,
Q141K
(50% function) and
Q126X
(no function), and used these to correlate ABCG2 function with age of gout onset.
Login to comment
50
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:50:43
status:
NEW
view ABCG2 p.Gln141Lys details
Of the 28 loci, the ABCG2 loci (rs2231142/
Q141K
mutation) resulted in the highest OR for gout risk (1.73) and contributed the largest increases in SUA (0.217 mg/dl) (12).
Login to comment
51
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:51:0
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:51:6
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:51:35
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:51:72
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:51:123
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:51:136
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:51:160
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.His155Ala
X
ABCG2 p.His155Ala 26136557:51:14
status:
NEW
view ABCG2 p.His155Ala details
ABCG2 p.His155Ala
X
ABCG2 p.His155Ala 26136557:51:84
status:
NEW
view ABCG2 p.His155Ala details
ABCG2 p.His155Ala
X
ABCG2 p.His155Ala 26136557:51:96
status:
NEW
view ABCG2 p.His155Ala details
ABCG2 p.His155Ala
X
ABCG2 p.His155Ala 26136557:51:144
status:
NEW
view ABCG2 p.His155Ala details
ABCG2 p.His155Ala
X
ABCG2 p.His155Ala 26136557:51:150
status:
NEW
view ABCG2 p.His155Ala details
Q141K
Q141K
/
H155A
0.00 0.25 0.50
Q141K
ABCG2 abundance relative to Wt
Q141K
ABCG2
H155A
-- --
H155A
GAPDH ABCG2 Wt ABCG2
Q141K
H155 2
Q141K
+
H155A
H155A
ICL
Q141K
/ Wt NBD B A C D ** Fig. 1.
Login to comment
52
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:52:0
status:
NEW
view ABCG2 p.Gln141Lys details
Q141K
gout-causing mutation changes NBD structure in a model of ABCG2.
Login to comment
53
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:53:26
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:53:124
status:
NEW
view ABCG2 p.Gln141Lys details
A: model comparing Wt and
Q141K
NBDs as described in Woodward et al. (32) reveals a shift in an adjacent loop (black arrow,
Q141K
in blue, Wt in green).
Login to comment
55
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:55:51
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.His155Ala
X
ABCG2 p.His155Ala 26136557:55:116
status:
NEW
view ABCG2 p.His155Ala details
C: biochemical confirmation of the model shows the
Q141K
mutant expression levels can be rescued with the secondary
H155A
substitution.
Login to comment
63
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:63:62
status:
NEW
view ABCG2 p.Gln141Lys details
Recent work has focused on the molecular defect caused by the
Q141K
mutation of ABCG2 as both a potential therapeutic target and also as a model for understanding the basic structure/ function biology of ABC transporters.
Login to comment
64
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:64:4
status:
NEW
view ABCG2 p.Gln141Lys details
The
Q141K
mutation occurs in a residue of the nucleotide-binding domain, a position believed critical for interactions with the intracellular loops of the transmembrane portion of the protein.
Login to comment
67
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:67:35
status:
NEW
view ABCG2 p.Gln141Lys details
A comparative analysis between the
Q141K
ABCG2 mutant and the èc;F508 CFTR mutant reveals striking similarities.
Login to comment
72
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:72:4
status:
NEW
view ABCG2 p.Gln141Lys details
The
Q141K
ABCG2 mutant appears to only cause instability in the NBD domain.
Login to comment
73
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:73:77
status:
NEW
view ABCG2 p.Gln141Lys details
We recently demonstrated that artificially stabilizing the NBD domain of the
Q141K
mutant corrects the molecular defect.
Login to comment
74
ABCG2 p.Gly188Glu
X
ABCG2 p.Gly188Glu 26136557:74:93
status:
NEW
view ABCG2 p.Gly188Glu details
Using either small molecules like the drug VRT-325 (11), or by using the suppressor mutation
G188E
to enhance NBD sandwich formation (25), we were able to rescue expression, trafficking, and function (32).
Login to comment
79
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:79:27
status:
NEW
view ABCG2 p.Gln141Lys details
The specific source of the
Q141K
instability has remained unresolved.
Login to comment
80
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:80:42
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:80:123
status:
NEW
view ABCG2 p.Gln141Lys details
Recently, we have found that modeling the
Q141K
and Wt ABCG2 NBD domains (32) suggested a loop adjacent to the site of the
Q141K
substitution (see Fig. 1A) appears to be shifted outward, resulting from a clash between the mutant 141K residue and a histidine residue at the top of the loop.
Login to comment
81
ABCG2 p.Gln141Lys
X
ABCG2 p.Gln141Lys 26136557:81:109
status:
NEW
view ABCG2 p.Gln141Lys details
ABCG2 p.His155Ala
X
ABCG2 p.His155Ala 26136557:81:116
status:
NEW
view ABCG2 p.His155Ala details
Replacing the histidine with an alanine appeared to resolve the shift and also significantly increased total
Q141K
(
H155A
) and mature, glycosylated protein abundance (Fig. 1, B-D) when expressed in HEK293 cells.
Login to comment